Risk of heart attack with antiepileptics of small clinical relevance on population level
Some antiepileptic drugs (AEDs), such as phenytoin induce liver enzymes, increasing lipid levels — a risk factor for heart attack and stroke. In contrast, the AED sodium valproate is a liver enzyme inhibitor and other, newer AEDs have a negligible effect.
Researchers used the UK Clinical Practice Research Datalink to compare patients newly prescribed different classes of antiepileptic drugs between 1990 and 2013 (n=252,407). Inducing drugs slightly increased the risk of ischaemic stroke compared with non-inducing AEDs (relative risk [RR]=1.16, 95% confidence interval [CI] 1.02 to 1.33) and when taken for two years or longer increased the risk of myocardial infarction by 46% (RR=1.46, 95% CI 1.15 to 1.85). Inhibiting AEDs slightly decreased myocardial infarction risk (RR=0.81, 95% CI 0.66 to 1.00).
Overall, the increased risk of myocardial infarction is most likely of small clinical relevance on a population level, the authors say in BMJ Open (online, 12 August 2015).
Citation: Electronicjuice DOI: 10.1211/PJ.2015.20069242
Recommended from Pharmaceutical Press
A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.£33.00
Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.£40.00
Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.£25.00
An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.£54.00
This unique textbook covers the role of basic pharmaceutics in clinical outcomes and in explaining the behaviour of medicines in the body.£27.00